Answers are grounded in this paper and cite their sources.
Acne Vulgaris (AV) is one of the most common skin disorders worldwide, impacting individuals across all races and ethnicities and primarily affecting the pilosebaceous glands. It is caused by excessive sebum production, thickening of the skin, and the growth of Propionibacterium acnes bacteria. The condition predominantly affects adolescents, with approximately 80% of teenagers diagnosed and around 85% of young people experiencing some form of acne. While it typically emerges during puberty, it can also occur in individuals up to 25 years or older, with males generally experiencing more severe cases. In Unani medicine, Buthur-i- Labaniyya is identified as small white spots on the nose and cheeks that resemble drops of milk. The principles of treatment (Usul-i-'Ilaj) focus on the Istifragh (evacuation) of phlegm from the body and brain, alongside the use of Mufattih (deobstruent), Jali (detergent), and Muhallil (resolvent) medications. This case study reports on a 28 year old female patient suffering from AV who had not previously received treatment. She was administered Habb-i-MufaffiKhun (HMK), two tablets twice daily, over four-week period. The patient exhibited significant improvement in her acne symptoms, highlighting the effectiveness of Unani formulation in managing this common condition. This study aims to underscore the potential of Unani medicine in treating Acne Vulgaris.
No takes yet. Share an insight, caveat, or question.
Ahamad et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: